Stoke is developing its lead candidate, zorevunersen (STK-001), for Dravet syndrome, a severe and progressive type of genetic epilepsy. It causes frequent, prolonged seizures in infancy, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback